Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
27 Agosto 2024 - 3:05PM
Business Wire
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
company, today announced the company will participate in the
upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in
New York, NY.
Guardant Health’s management is scheduled to participate in a
fireside chat on Thursday, September 5th at 11:30 a.m. ET.
Interested parties may access live and archived webcasts of the
sessions on the “Investors” section of the company website at:
www.guardanthealth.com.
About Guardant Health
Guardant Health is a leading precision oncology company focused
on guarding wellness and giving every person more time free from
cancer. Founded in 2012, Guardant is transforming patient care and
accelerating new cancer therapies by providing critical insights
into what drives disease through its advanced blood and tissue
tests, real-world data and AI analytics. Guardant tests help
improve outcomes across all stages of care, including screening to
find cancer early, monitoring for recurrence in early-stage cancer,
and treatment selection for patients with advanced cancer. For more
information, visit guardanthealth.com and follow the company on
LinkedIn, X (Twitter) and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240827242654/en/
Investor Contact: Zarak Khurshid
investors@guardanthealth.com
Media Contact: Melissa Marasco press@guardanthealth.com
+1 650-647-3711
Guardant Health (NASDAQ:GH)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Guardant Health (NASDAQ:GH)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
